Requirement for cellular cyclin-dependent kinases in herpes simplex virus replication and transcription.
about
Herpes simplex virus transactivator VP16 discriminates between HCF-1 and a novel family member, HCF-2.Roscovitine, a specific inhibitor of cellular cyclin-dependent kinases, inhibits herpes simplex virus DNA synthesis in the presence of viral early proteinsExplant-induced reactivation of herpes simplex virus occurs in neurons expressing nuclear cdk2 and cdk4Roscovitine inhibits activation of promoters in herpes simplex virus type 1 genomes independently of promoter-specific factorsUse of a multi-virus array for the study of human viral and retroviral pathogens: gene expression studies and ChIP-chip analysisMacrophages and cytokines in the early defence against herpes simplex virusCurrent and potential treatments for ubiquitous but neglected herpesvirus infectionsPhosphoproteomic analyses reveal signaling pathways that facilitate lytic gammaherpesvirus replicationClassic swine fever virus NS2 protein leads to the induction of cell cycle arrest at S-phase and endoplasmic reticulum stressInhibition of human immunodeficiency virus type 1 transcription by chemical cyclin-dependent kinase inhibitorsPosttranslational processing of infected cell proteins 0 and 4 of herpes simplex virus 1 is sequential and reflects the subcellular compartment in which the proteins localizeBinding of herpes simplex virus type-1 virions leads to the induction of intracellular signalling in the absence of virus entryVaricella-zoster virus Fc receptor component gI is phosphorylated on its endodomain by a cyclin-dependent kinaseB-myb promoter retargeting of herpes simplex virus gamma34.5 gene-mediated virulence toward tumor and cycling cellsTranscription of herpes simplex virus immediate-early and early genes is inhibited by roscovitine, an inhibitor specific for cellular cyclin-dependent kinasesThe disappearance of cyclins A and B and the increase in activity of the G(2)/M-phase cellular kinase cdc2 in herpes simplex virus 1-infected cells require expression of the alpha22/U(S)1.5 and U(L)13 viral genes.E2F proteins are posttranslationally modified concomitantly with a reduction in nuclear binding activity in cells infected with herpes simplex virus 1.The murine gammaherpesvirus 68 v-cyclin gene is an oncogene that promotes cell cycle progression in primary lymphocytes.Transactivation of herpes simplex virus type 1 immediate-early gene expression by virion-associated factors is blocked by an inhibitor of cyclin-dependent protein kinasesPhosphorylation of the herpes simplex virus type 1 origin binding protein.Efficient activation of viral genomes by levels of herpes simplex virus ICP0 insufficient to affect cellular gene expression or cell survival.Herpesvirus lytic replication and the cell cycle: arresting new developmentsGene array analysis reveals changes in peripheral nervous system gene expression following stimuli that result in reactivation of latent herpes simplex virus type 1: induction of transcription factor Bcl-3.cdc2 cyclin-dependent kinase binds and phosphorylates herpes simplex virus 1 U(L)42 DNA synthesis processivity factorCREB/ATF-dependent repression of cyclin a by human T-cell leukemia virus type 1 Tax protein.DNA repair proteins affect the lifecycle of herpes simplex virus 1.HSV-1-based vectors for gene therapy of neurological diseases and brain tumors: part I. HSV-1 structure, replication and pathogenesis.Inhibition of cyclin-dependent kinase 1 by purines and pyrrolo[2,3-d]pyrimidines does not correlate with antiviral activityThe cyclin-dependent kinase inhibitor roscovitine inhibits the transactivating activity and alters the posttranslational modification of herpes simplex virus type 1 ICP0.Pharmacological cyclin-dependent kinase inhibitors inhibit replication of wild-type and drug-resistant strains of herpes simplex virus and human immunodeficiency virus type 1 by targeting cellular, not viral, proteinsBeta interferon and gamma interferon synergize to block viral DNA and virion synthesis in herpes simplex virus-infected cells.Identification of homeodomain proteins, PBX1 and PREP1, involved in the transcription of murine leukemia virus.Inhibition of S-phase cyclin-dependent kinase activity blocks expression of Epstein-Barr virus immediate-early and early genes, preventing viral lytic replicationCellular stress rather than stage of the cell cycle enhances the replication and plating efficiencies of herpes simplex virus type 1 ICP0- virusesThe differential mobilization of histones H3.1 and H3.3 by herpes simplex virus 1 relates histone dynamics to the assembly of viral chromatinHerpes simplex virus type 1 and bovine herpesvirus 1 latency.CK2 inhibitors increase the sensitivity of HSV-1 to interferon-β.Analysis of the cell cycle regulatory protein (E2F1) after infection of cultured cells with bovine herpesvirus 1 (BHV-1) or herpes simplex virus type 1 (HSV-1)Emerin is hyperphosphorylated and redistributed in herpes simplex virus type 1-infected cells in a manner dependent on both UL34 and US3.Novel cell type-specific antiviral mechanism of interferon gamma action in macrophages
P2860
Q22009165-60CA912B-95B5-4666-8E60-FFC045EC31F0Q24524449-8B761CF7-FAA3-401F-AF9E-ACB85771B726Q24537780-E7BC1192-5E5E-4F85-8BF2-887961A41F1DQ24562983-C558F554-09E0-48C5-9388-6730244C6A8BQ24799552-34E75AD8-CD6D-4593-8A6C-6C3A93E1ED55Q24815062-04F97D3B-E725-4163-BFDC-CDCC6482F362Q27023452-ED5EB5AF-1577-4A06-B80C-347ADD8BE051Q27333727-02FE8392-33AC-4679-913C-20E1256FCE3EQ27490910-6D726983-C2E1-4822-8150-0A445A73AD1BQ28344365-1719DD7B-A723-4746-9B80-0AE82C679DEBQ28345181-55AFCBDA-70C4-4160-A823-FB0A2AE75A68Q33539774-3AC0B1A6-B48E-48BB-8110-264AE0297699Q33641265-59E38F07-9326-49F1-985E-6B312D718F67Q33649894-1C6643DC-D937-414B-9D5B-1912E1816AD9Q33653316-23E600DE-C4A0-499E-BEFA-468288174830Q33794196-5B6BD3F3-7CA2-4208-827E-76A204A0A093Q33810415-993A426B-B917-4896-8D80-BB2EA1621B27Q33814440-BD37B002-6969-493C-90BE-03AEC452462EQ33821462-CB3449CE-EA1B-4291-BB50-C77DC1D5BF61Q33835285-70381ECA-2D4A-4E0F-B6D4-B196BB90B21AQ33838501-B1774FF1-56D6-4A87-A55D-0E3C4C91E26EQ33840180-FDA2E09E-80F3-4102-A727-F97146C01575Q33847005-D503E7D5-FF38-4101-8B52-34ED342282E6Q33847970-45A49AEB-95C6-4088-8A19-480278C58B2EQ33850537-4331C5B2-CD70-4DBE-BB87-7B90202DF747Q33936284-E5C519BC-D56B-4322-B1FA-44264132F4ECQ33995747-D0FFB9F2-9067-4BFB-9DA0-A0D1C7AA9583Q34111307-92E2F6EB-0B47-4347-BAD4-A3F4C58895FCQ34330457-CCA9A539-C8E5-40A2-932D-18378ADDFA5DQ34343774-5F5AEE58-8DDE-4386-900A-4A13104615D7Q34350245-F6406EEA-3594-4149-82B5-5969CFCE9B30Q34463374-93F425E2-6FF7-47D1-94D5-42DD429BE145Q34553293-AD780BAC-9E68-4890-B5D6-A52F6BEC87C3Q34647412-91EB22E8-856D-4924-B71C-AEE5EB920405Q35018071-59528EA0-FB22-48E4-A365-E244C16F499FQ35044114-85F68415-7510-4033-8907-96F73E6F29AEQ35175764-F8F01AF6-7628-488D-8AF6-8087AD738FE3Q35186351-E789AAE4-FA84-4AE9-AC1D-952F09CAD985Q36099092-F5EACC45-B41D-4F4F-BA41-4101D37DAF04Q36376172-2750F3F2-178C-4234-8DF0-A030CED4B1B9
P2860
Requirement for cellular cyclin-dependent kinases in herpes simplex virus replication and transcription.
description
1998 nî lūn-bûn
@nan
1998 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
1998 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
1998年の論文
@ja
1998年論文
@yue
1998年論文
@zh-hant
1998年論文
@zh-hk
1998年論文
@zh-mo
1998年論文
@zh-tw
1998年论文
@wuu
name
Requirement for cellular cycli ...... replication and transcription.
@ast
Requirement for cellular cycli ...... replication and transcription.
@en
type
label
Requirement for cellular cycli ...... replication and transcription.
@ast
Requirement for cellular cycli ...... replication and transcription.
@en
prefLabel
Requirement for cellular cycli ...... replication and transcription.
@ast
Requirement for cellular cycli ...... replication and transcription.
@en
P2093
P2860
P1433
P1476
Requirement for cellular cycli ...... replication and transcription.
@en
P2093
J Phillips
L M Schang
P A Schaffer
P2860
P304
P577
1998-07-01T00:00:00Z